Methyldopate Hydrochloride
L-Tyrosine,3-hydroxy-a-methyl-,ethyl ester,hydrochloride. L-3-(3,4-Dihydroxyphenyl)-2-methylalanine ethyl ester hydrochloride [5123-53-5;2508-79-4]. »Methyldopate Hydrochloride contains not less than 98.0percent and not more than 101.0percent of C12H17NO4·HCl,calculated on the dried basis.
Packaging and storage
Preserve in well-closed containers.Store at 25
![]() ![]() ![]()
Identification
B:Ultraviolet Absorption á197Uñ
Solution:
50µg per mL.
Medium:
0.1Nhydrochloric acid.
Absorptivities at 280nm,calculated on the dried basis,do not differ by more than 3.0%.
D:
It responds to the tests for Chloride á191ñ,except that on the addition of the slight excess of 6Nammonium hydroxide a brown precipitate is formed.
Specific rotation á781Sñ:
between -13.5
![]() ![]()
Test solution:
40mg per mL,in 0.1Nhydrochloric acid.
pHá791ñ:
between 3.0and 5.0,in a solution (1in 100).
Loss on drying á731ñ
Dry it at 100
![]()
Residue on ignition á281ñ:
not more than 0.1%.
Heavy metals,Method IIá231ñ:
0.001%.
Assay
Mobile solvent
Prepare a suitable solution of 0.02Mmonobasic sodium phosphate and 0.015Mphosphoric acid in a water and methanol solution (approximately 15.5:4.5)such that the retention time of methyldopate hydrochloride is approximately 6.5minutes.
Standard preparation
Dissolve an accurately weighed quantity of USP Methyldopate Hydrochloride RSin the Mobile solventto obtain a solution containing about 1mg per mL.
Assay preparation
Transfer about 50mg of Methyldopate Hydrochloride,accurately weighed,to a 50-mLvolumetric flask,dissolve in and dilute with Mobile solventto volume.
Procedure
Introduce separately 20-µLportions of the Assay preparationand the Standard preparationinto a high-pressure liquid chromatograph (see Chromatography á621ñ)operated at 25
![]() 50C(AU/AS),
in which Cis the concentration,in mg per mL,of USP Methyldopate Hydrochloride RSin the Standard preparation;and AUand ASare the peak areas obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information
Staff Liaison:Andrzej Wilk,Ph.D.,Senior Scientific Associate
Expert Committee:(PA5)Pharmaceutical Analysis 5
USP28NF23Page 1262
Pharmacopeial Forum:Volume No.29(5)Page 1534
Phone Number:1-301-816-8305
|